Sign In
Buy GRCL
$10.25
+0 (+0%)
At Close: May 20, 2024
Week In Review: China Biopharma Starts 2021 With Over $1 Billion In Deals And IPOs
03:16pm, Sunday, 10'th Jan 2021
Gracell Biotech completed a $209 million NASDAQ IPO for its next-gen CAR-T treatments. Zai Lab acquired greater China rights to an argenx SE novel treatment for autoimmune indications in a deal worth
U.S. IPO Weekly Recap: The New Year Kicks Off With 2 Biotech IPOs And A Tidal Wave Of SPACs
06:26am, Saturday, 09'th Jan 2021
U.S. IPO Weekly Recap: The New Year Kicks Off With 2 Biotech IPOs And A Tidal Wave Of SPACs
